Position in JNJ
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$343,367
+$13,129 QoQ
Shares Held
1,352
+0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.18%
of 13F equity value
Holder Rank
#4,046
of 4,664 holders
Holding Since
Dec 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026REBALANCE, LLC holds $1,260,922 across 3 Drug Manufacturers - General names. JNJ ranks #2 (27.2% of the industry book) .
All Filings in JNJ
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $343,367 | 1,352 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $330,238 | 1,351 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $293,869 | 1,420 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $249,946 | 1,348 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $238,290 | 1,560 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $258,378 | 1,558 | Shares | Sole | 2025-04-17 | |
| 2024-09-30 | $217,808 | 1,344 | Shares | Sole | 2024-10-22 | |
| 2022-12-31 | $14,308 | 81 | Shares | Sole | 2023-02-27 | |
| No filing history on record for this holder in this stock. | ||||||